Meal consumption in the evening is greater in obese adolescents compared with overweight or normal weight subjects, with later circadian phase of peak intake and lower amplitude.
Treatment for adolescent obesity should be guided by patient age, pubertal status, severity of obesity, psychosocial factors, and comorbidities.
Nationwide, 4.8 million young people ages 10 to 17 years have obesity.
Transgender youth on gender-affirming hormone therapy have differences in their percent fat and lean mass compared with cisgender youth.
Receiving 12 weeks of probiotic supplement can improve body mass index as well as components of the inflammatory and glycolipid metabolism in obese children.
The FDA has expanded the approval of Crysvita (burosumab; Ultragenyx and Kyowa Kirin) to include treatment in pediatric patients as young as 6 months with X-linked hypophosphatemia.
Increasing evening chronotypes and social jet lag are associated with increased adiposity in adolescent girls.
Colophonium, a fast-acting adhesive and known sensitizing allergen, may cause dermatologic reactions in children using devices to manage diabetes.
Maternal cholecalciferol supplementation may have lasting benefits for offspring musculoskeletal health.
There are significant relationships between bone marrow density, visceral adipose tissue, and bone indices in children.
